Our results showed that combined NXD30001 and radiotherapy may improve the antineoplastic activity in GBM through inhibiting GSCs proliferation and enhancing cell apoptosis by attenuating phosphorylation of multiple Hsp90 client proteins. This evidence concerns the gene HSP90AB1 and glioblastoma.